Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G HALE

Showing results (301-310 of 354) with videos related to

Pageof 36
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1993
A humanized CD18 antibody can block function without cell destructionM J Sims, D G Hassal, S Brett, et al.
Nihon Geka Gakkai Zasshi|April 25, 2000
Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipientsR Calne, S D Moffatt, P J Friend, et al.
Transplantation|December 10, 1999
Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipientsR Calne, S D Moffatt, P J Friend, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activationSadaf Aslam, María T Sánchez-Aparicio, Braden D Siempelkamp, et al.
Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|September 29, 2018
Localized low-dose rhBMP-2 is effective at promoting bone regeneration in mandibular segmental defectsPatricia Carlisle, Teja Guda, David T Silliman, et al.
Experimental Hematology|July 2, 1999
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodiesE Naparstek, M Delukina, R Or, et al.
Human Molecular Genetics|December 1, 1996
Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosisX Y Zhou, A van der Spoel, R Rottier, et al.
The Journal of General Virology|July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivirMarie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.
Plos Biology|July 5, 2022
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus diseaseIdoia Busnadiego, Irene A Abela, Pascal M Frey, et al.
Pageof 36

Showing results (301-310 of 354) with videos related to

Sort By:
Pageof 36
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1993
A humanized CD18 antibody can block function without cell destructionM J Sims, D G Hassal, S Brett, et al.
Nihon Geka Gakkai Zasshi|April 25, 2000
Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipientsR Calne, S D Moffatt, P J Friend, et al.
Transplantation|December 10, 1999
Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipientsR Calne, S D Moffatt, P J Friend, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activationSadaf Aslam, María T Sánchez-Aparicio, Braden D Siempelkamp, et al.
Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|September 29, 2018
Localized low-dose rhBMP-2 is effective at promoting bone regeneration in mandibular segmental defectsPatricia Carlisle, Teja Guda, David T Silliman, et al.
Experimental Hematology|July 2, 1999
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodiesE Naparstek, M Delukina, R Or, et al.
Human Molecular Genetics|December 1, 1996
Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosisX Y Zhou, A van der Spoel, R Rottier, et al.
The Journal of General Virology|July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivirMarie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.
Plos Biology|July 5, 2022
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus diseaseIdoia Busnadiego, Irene A Abela, Pascal M Frey, et al.
Pageof 36